Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

ANK C/X Impl A14/D3.5/L14: medical device reports filed with FDA

2,849 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

2,849
device reports naming the brand
0% of all MAUDE reports · about 402 a year
402
reports, 12 months to August 2026
350 in the 12 months before
0.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,849 medical device reports received by FDA name the brand "ANK C/X Impl A14/D3.5/L14" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

402 reports arrived in the 12 months to August 2026, up 15% from 350 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and malfunction (0.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (38.8%), osseointegration problem (31.3%) and loss of osseointegration (22.7%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03671Sep 2021: 20Oct 2021: 39Nov 2021: 62Dec 2021: 442022Jan 2022: 61Feb 2022: 41Mar 2022: 28Apr 2022: 54May 2022: 58Jun 2022: 56Jul 2022: 33Aug 2022: 46Sep 2022: 28Oct 2022: 28Nov 2022: 34Dec 2022: 352023Jan 2023: 40Feb 2023: 60Mar 2023: 30Apr 2023: 49May 2023: 41Jun 2023: 31Jul 2023: 40Aug 2023: 35Sep 2023: 27Oct 2023: 42Nov 2023: 34Dec 2023: 262024Jan 2024: 42Feb 2024: 48Mar 2024: 36Apr 2024: 46May 2024: 26Jun 2024: 45Jul 2024: 43Aug 2024: 71Sep 2024: 21Oct 2024: 35Nov 2024: 21Dec 2024: 122025Jan 2025: 22Feb 2025: 30Mar 2025: 53Apr 2025: 19May 2025: 19Jun 2025: 30Jul 2025: 46Aug 2025: 42Sep 2025: 34Oct 2025: 28Nov 2025: 26Dec 2025: 312026Jan 2026: 49Feb 2026: 44Mar 2026: 27Apr 2026: 45May 2026: 25Jun 2026: 40Jul 2026: 31Aug 2026: 22

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03577142019: 6920192021: 71420212022: 50220222023: 45520232024: 44620242025: 38020252026: 2832026

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.9%2,846
Malfunction0.1%3
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%2,849
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,10638.8%62.8%
Osseointegration problem89131.3%7.7%
Loss of osseointegration64722.7%22.4%
Fracturea broken bone2017.1%1.6%
Loosening of implant not related to bone-ingrowth30.1%0.1%
Separation failure20.1%0.1%
Damaged thread10%0%
Detachment of device or device componentpart of the device came off10%0%
Malposition of device10%0.1%
Material deformation10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant2,84199.7%
Inflammationinflammation31911.2%
Osteolysis1886.6%
Pocket erosion1475.2%
Implant pain100.4%
Deformity/ disfigurement40.1%
Fistula20.1%
Painpain, site not specified20.1%
Swelling/ edema20.1%
Abscessa collection of pus10%
Eye irritationeye irritation10%
Hypersensitivity/allergic reaction10%
Inadequate osseointegration10%
Laceration(s)10%
Localized skin lesion10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureANK C/X Impl A14/D3.5/L14Product code DZEAll MAUDE reports
Reports2,8493,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury99.9%99.2%36.2%
Classified as malfunction0.1%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about ANK C/X Impl A14/D3.5/L14 reports

How many FDA reports name ANK C/X Impl A14/D3.5/L14?

2,849 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 402 in the latest 12 months.

What kinds of events are reported?

injury (99.9%) and malfunction (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (38.8%), osseointegration problem (31.3%), loss of osseointegration (22.7%), fracture (7.1%) and loosening of implant not related to bone-ingrowth (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that ANK C/X Impl A14/D3.5/L14 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.